{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:01:14Z","timestamp":1786122074864,"version":"build-2736575974"},"reference-count":159,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>Dilated cardiomyopathy (DCM) is the most common cardiomyopathy in children and a leading indication for heart transplantation. Despite considerable progress in understanding its genetic architecture, translating these insights into improved outcomes for children remains challenging. The pathophysiology of pediatric dilated cardiomyopathy is highly complex, extending beyond a simple monogenic model to encompass intricate interactions between genetic predisposition, inflammatory triggers, and metabolic dysregulation. This review systematically synthesizes current evidence on the mechanisms driving heart failure progression in pediatric dilated cardiomyopathy, focusing on the integrated framework of the \u201cgene-inflammation-metabolism\u201d axis. We begin by outlining the genetic landscape of pediatric dilated cardiomyopathy, highlighting key pathogenic genes and their associated phenotypes, with particular emphasis on features distinct from adult disease. We then explore how environmental \u201csecond hits\u201d (such as viral infection and autoimmune responses) trigger excessive inflammatory reactions, and discuss the significance of special clinical phenomena such as \u201chot phase\u201d myocarditis in genetically susceptible children. Concurrently, we systematically examine the metabolic reprogramming of the failing heart, including mitochondrial dysfunction, substrate utilization shifts, insulin resistance, and iron metabolism disturbances, analyzing how these processes further compromise energy-starved cardiomyocytes. By integrating these three interconnected domains, this review presents a pediatric-specific triaxial framework that unifies known DCM pathways into a single actionable model for precision risk stratification and targeted therapy. This framework supports the development of novel biomarkers, multi-dimensional risk stratification strategies, and targeted interventions\u2014ranging from anti-inflammatory agents and metabolic modulators to gene therapy, psychological support, and AI-assisted risk prediction. This review aims to provide a novel theoretical framework and practical roadmap for the clinical management and future research of pediatric dilated cardiomyopathy.<\/jats:p>","DOI":"10.3389\/fcvm.2026.1888470","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T08:39:08Z","timestamp":1786091948000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Pediatric dilated cardiomyopathy and the progression to heart failure: mechanisms and interventions focusing on the \u201cgene-inflammation-metabolism\u201d axis"],"prefix":"10.3389","volume":"13","author":[{"given":"Jinsong","family":"Jiang","sequence":"first","affiliation":[{"name":"Department of Non-Communicable Disease Management, Beijing Children\u2019s Hospital, Capital Medical University, National Center for Children\u2019s Health","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Non-Communicable Disease Management, Beijing Children\u2019s Hospital, Capital Medical University, National Center for Children\u2019s Health","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Gu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Beijing Children\u2019s Hospital, Capital Medical University, National Center for Children\u2019s Health","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyu","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Non-Communicable Disease Management, Beijing Children\u2019s Hospital, Capital Medical University, National Center for Children\u2019s Health","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Beijing Children\u2019s Hospital, Capital Medical University, National Center for Children\u2019s Health","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aihua","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Non-Communicable Disease Management, Beijing Children\u2019s Hospital, Capital Medical University, National Center for Children\u2019s Health","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s10741-020-09987-z","article-title":"Pathogenesis of chronic heart failure: cardiovascular aging, risk factors, comorbidities, and disease modifiers","volume":"27","author":"Triposkiadis","year":"2022","journal-title":"Heart Fail Rev"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1001\/jama.296.15.1867","article-title":"Incidence, causes, and outcomes of dilated cardiomyopathy in children","volume":"296","author":"Towbin","year":"2006","journal-title":"JAMA"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1161\/CIR.0000000000000682","article-title":"Cardiomyopathy in children: classification and diagnosis: a scientific statement from the American Heart Association","volume":"140","author":"Lipshultz","year":"2019","journal-title":"Circulation"},{"key":"B4","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41572-019-0084-1","article-title":"Dilated cardiomyopathy","volume":"5","author":"Schultheiss","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1056\/NEJMoa021737","article-title":"The epidemiology of childhood cardiomyopathy in Australia","volume":"348","author":"Nugent","year":"2003","journal-title":"N Engl J Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e003450","DOI":"10.1161\/JAHA.116.003450","article-title":"Natural history of dilated cardiomyopathy in children","volume":"5","author":"Puggia","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"B7","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","article-title":"2023 Focused update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"44","author":"McDonagh","year":"2023","journal-title":"Eur Heart J"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e895","DOI":"10.1161\/CIR.0000000000001063","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1016\/j.healun.2009.05.027","article-title":"Outcome of pediatric patients with dilated cardiomyopathy listed for transplant: a multi-institutional study","volume":"28","author":"Kirk","year":"2009","journal-title":"J Heart Lung Transplant"},{"key":"B10","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.ajhg.2021.12.006","article-title":"The genetic architecture of pediatric cardiomyopathy","volume":"109","author":"Ware","year":"2022","journal-title":"Am J Hum Genet"},{"key":"B11","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.cardfail.2012.01.017","article-title":"Pediatric cardiomyopathy: importance of genetic and metabolic evaluation","volume":"18","author":"Kindel","year":"2012","journal-title":"J Card Fail"},{"key":"B12","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/nrcardio.2013.105","article-title":"Dilated cardiomyopathy: the complexity of a diverse genetic architecture","volume":"10","author":"Hershberger","year":"2013","journal-title":"Nat Rev Cardiol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.ijcard.2016.09.068","article-title":"Genetic basis of dilated cardiomyopathy","volume":"224","author":"P\u00e9rez-Serra","year":"2016","journal-title":"Int J Cardiol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1056\/NEJMoa1505517","article-title":"Shared genetic predisposition in peripartum and dilated cardiomyopathies","volume":"374","author":"Ware","year":"2016","journal-title":"N Engl J Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s11886-020-1260-3","article-title":"Second hits in dilated cardiomyopathy","volume":"22","author":"Marstrand","year":"2020","journal-title":"Curr Cardiol Rep"},{"key":"B16","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/S0140-6736(23)01241-2","article-title":"Dilated cardiomyopathy: causes, mechanisms, and current and future treatment approaches","volume":"402","author":"Heymans","year":"2023","journal-title":"Lancet (London, England)"},{"key":"B17","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s10557-020-07071-0","article-title":"Inflammatory cytokines and chemokines as therapeutic targets in heart failure","volume":"34","author":"Hanna","year":"2020","journal-title":"Cardiovasc Drugs Ther"},{"key":"B18","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1161\/CIRCRESAHA.124.323800","article-title":"Mitochondrial structure and function in human heart failure","volume":"135","author":"Hinton","year":"2024","journal-title":"Circ Res"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.3390\/ijms25052667","article-title":"Mitochondrial dysfunction in heart failure: from pathophysiological mechanisms to therapeutic opportunities","volume":"25","author":"Gallo","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B20","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.ijcard.2016.11.045","article-title":"Familial dilated cardiomyopathy: a multidisciplinary entity, from basic screening to novel circulating biomarkers","volume":"228","author":"de Gonzalo-Calvo","year":"2017","journal-title":"Int J Cardiol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e003686","DOI":"10.1161\/CIRCGEN.121.003686","article-title":"Genetic basis of childhood cardiomyopathy","volume":"15","author":"Bagnall","year":"2022","journal-title":"Circ Genom Precis Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1161\/CIRCRESAHA.116.309386","article-title":"Pediatric cardiomyopathies","volume":"121","author":"Lee","year":"2017","journal-title":"Circ Res"},{"key":"B23","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1002\/ejhf.255","article-title":"A systematic analysis of genetic dilated cardiomyopathy reveals numerous ubiquitously expressed and muscle-specific genes","volume":"17","author":"Harakalova","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"B24","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1056\/NEJMoa1110186","article-title":"Truncations of titin causing dilated cardiomyopathy","volume":"366","author":"Herman","year":"2012","journal-title":"N Engl J Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1161\/CIRCULATIONAHA.112.139717","article-title":"Titin is a major human disease gene","volume":"127","author":"LeWinter","year":"2013","journal-title":"Circulation"},{"key":"B26","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1161\/01.CIR.0000135591.37759.AF","article-title":"Altered titin expression, myocardial stiffness, and left ventricular function in patients with dilated cardiomyopathy","volume":"110","author":"Nagueh","year":"2004","journal-title":"Circulation"},{"key":"B27","doi-asserted-by":"publisher","first-page":"270ra6","DOI":"10.1126\/scitranslmed.3010134","article-title":"Integrated allelic, transcriptional, and phenomic dissection of the cardiac effects of titin truncations in health and disease","volume":"7","author":"Roberts","year":"2015","journal-title":"Sci Transl Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1126\/science.aaa5458","article-title":"HEART DISEASE. Titin mutations in iPS cells define sarcomere insufficiency as a cause of dilated cardiomyopathy","volume":"349","author":"Hinson","year":"2015","journal-title":"Science (New York, NY)"},{"key":"B29","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1161\/CIRCGENETICS.112.962928","article-title":"Population-based variation in cardiomyopathy genes","volume":"5","author":"Golbus","year":"2012","journal-title":"Circ Cardiovasc Genet"},{"key":"B30","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/ng.3719","article-title":"Titin-truncating variants affect heart function in disease cohorts and the general population","volume":"49","author":"Schafer","year":"2017","journal-title":"Nat Genet"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1136\/heartjnl-2016-311017","article-title":"Association between mutation status and left ventricular reverse remodelling in dilated cardiomyopathy","volume":"103","author":"Dal Ferro","year":"2017","journal-title":"Heart"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e006832","DOI":"10.1161\/CIRCHEARTFAILURE.119.006832","article-title":"Clinical phenotypes and prognosis of dilated cardiomyopathy caused by truncating variants in the TTN gene","volume":"13","author":"Akhtar","year":"2020","journal-title":"Circ Heart Fail"},{"key":"B33","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/S0735-1097(02)02954-6","article-title":"Natural history of dilated cardiomyopathy due to lamin A\/C gene mutations","volume":"41","author":"Taylor","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1242\/dmm.006346","article-title":"LMNA Cardiomyopathy: cell biology and genetics meet clinical medicine","volume":"4","author":"Lu","year":"2011","journal-title":"Dis Model Mech"},{"key":"B35","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.jacc.2011.08.078","article-title":"Risk factors for malignant ventricular arrhythmias in lamin a\/c mutation carriers a European cohort study","volume":"59","author":"van Rijsingen","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1016\/j.jacc.2019.06.072","article-title":"Genetic risk of arrhythmic phenotypes in patients with dilated cardiomyopathy","volume":"74","author":"Gigli","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1161\/CIRCULATIONAHA.118.039410","article-title":"Development and validation of a new risk prediction score for life-threatening ventricular tachyarrhythmias in laminopathies","volume":"140","author":"Wahbi","year":"2019","journal-title":"Circulation"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1016\/j.jacc.2008.06.044","article-title":"Long-term outcome and risk stratification in dilated cardiolaminopathies","volume":"52","author":"Pasotti","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"144ra02","DOI":"10.1126\/scitranslmed.3003875","article-title":"Temsirolimus activates autophagy and ameliorates cardiomyopathy caused by lamin A\/C gene mutation","volume":"4","author":"Choi","year":"2012","journal-title":"Sci Transl Med"},{"key":"B40","doi-asserted-by":"publisher","first-page":"e003730","DOI":"10.1161\/CIRCGEN.122.003730","article-title":"Efficacy and safety of ARRY-371797 in LMNA-related dilated cardiomyopathy: a phase 2 study","volume":"16","author":"MacRae","year":"2023","journal-title":"Circ Genom Precis Med"},{"key":"B41","doi-asserted-by":"publisher","first-page":"e301","DOI":"10.1016\/j.hrthm.2019.05.007","article-title":"2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy","volume":"16","author":"Towbin","year":"2019","journal-title":"Heart Rhythm"},{"key":"B42","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1161\/CIRCULATIONAHA.119.037661","article-title":"Reevaluating the genetic contribution of monogenic dilated cardiomyopathy","volume":"141","author":"Mazzarotto","year":"2020","journal-title":"Circulation"},{"key":"B43","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1161\/CIRCULATIONAHA.120.053033","article-title":"Evidence-Based assessment of genes in dilated cardiomyopathy","volume":"144","author":"Jordan","year":"2021","journal-title":"Circulation"},{"key":"B44","doi-asserted-by":"publisher","first-page":"6701","DOI":"10.1073\/pnas.1606950113","article-title":"Multidimensional structure-function relationships in human \u03b2-cardiac myosin from population-scale genetic variation","volume":"113","author":"Homburger","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B45","doi-asserted-by":"publisher","first-page":"e015316","DOI":"10.1161\/JAHA.119.015316","article-title":"Increased myocardial oxygen consumption precedes Contractile dysfunction in hypertrophic cardiomyopathy caused by pathogenic TNNT2 gene variants","volume":"9","author":"Parbhudayal","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"B46","doi-asserted-by":"publisher","first-page":"10510","DOI":"10.3390\/ijms241310510","article-title":"An update on MYBPC3 gene mutation in hypertrophic cardiomyopathy","volume":"24","author":"Tudurachi","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B47","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1161\/CIRCGEN.120.002969","article-title":"Categorized genetic analysis in childhood-onset cardiomyopathy","volume":"13","author":"Al-Hassnan","year":"2020","journal-title":"Circ Genom Precis Med"},{"key":"B48","doi-asserted-by":"publisher","first-page":"e002981","DOI":"10.1161\/CIRCGEN.120.002981","article-title":"Genetic evaluation of A nation-wide Dutch pediatric DCM cohort: the use of genetic testing in risk stratification","volume":"15","author":"van Der Meulen","year":"2022","journal-title":"Circ Genom Precisi Med"},{"key":"B49","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1038\/s41436-020-01049-x","article-title":"Systematic large-scale assessment of the genetic architecture of left ventricular noncompaction reveals diverse etiologies","volume":"23","author":"Mazzarotto","year":"2021","journal-title":"Genet Med"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1002\/humu.24004","article-title":"A mutation update for the FLNC gene in myopathies and cardiomyopathies","volume":"41","author":"Verdonschot","year":"2020","journal-title":"Hum Mutat"},{"key":"B51","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1016\/j.jacc.2016.09.927","article-title":"Truncating FLNC mutations are associated with high-risk dilated and arrhythmogenic cardiomyopathies","volume":"68","author":"Ortiz-Genga","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1161\/CIRCULATIONAHA.119.044934","article-title":"Desmoplakin cardiomyopathy, a fibrotic and inflammatory form of cardiomyopathy distinct from typical dilated or arrhythmogenic right ventricular cardiomyopathy","volume":"141","author":"Smith","year":"2020","journal-title":"Circulation"},{"key":"B53","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1093\/europace\/euaa343","article-title":"\u2018Hot phase\u2019 clinical presentation in arrhythmogenic cardiomyopathy","volume":"23","author":"Bariani","year":"2021","journal-title":"Europace"},{"key":"B54","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.1093\/eurheartj\/ehac235","article-title":"Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculator","volume":"43","author":"Protonotarios","year":"2022","journal-title":"Eur Heart J"},{"key":"B55","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/j.1752-8062.2010.00198.x","article-title":"Identification of novel mutations in RBM20 in patients with dilated cardiomyopathy","volume":"3","author":"Li","year":"2010","journal-title":"Clin Transl Sci"},{"key":"B56","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1161\/CIRCGEN.123.004059","article-title":"Risks of ventricular arrhythmia and heart failure in carriers of RBM20 variants","volume":"16","author":"Cannie","year":"2023","journal-title":"Circulation Genomic and Precision Medicine"},{"key":"B57","doi-asserted-by":"publisher","first-page":"e005371","DOI":"10.1161\/CIRCHEARTFAILURE.118.005371","article-title":"Regional variation in RBM20 causes a highly penetrant arrhythmogenic cardiomyopathy","volume":"12","author":"Parikh","year":"2019","journal-title":"Circulation Heart Failure"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1002\/humu.24096","article-title":"Cardiomyopathy-associated mutations in the RS domain affect nuclear localization of RBM20","volume":"41","author":"Gaertner","year":"2020","journal-title":"Hum Mutat"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1073\/pnas.0510519103","article-title":"A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy","volume":"103","author":"Haghighi","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1093\/eurjhf\/hfs119","article-title":"Phospholamban R14del mutation in patients diagnosed with dilated cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy: evidence supporting the concept of arrhythmogenic cardiomyopathy","volume":"14","author":"van Der Zwaag","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"B61","doi-asserted-by":"publisher","first-page":"2842","DOI":"10.1093\/eurheartj\/ehab294","article-title":"Prediction of ventricular arrhythmia in phospholamban p.Arg14del mutation carriers-reaching the frontiers of individual risk prediction","volume":"42","author":"Verstraelen","year":"2021","journal-title":"Eur Heart J"},{"key":"B62","doi-asserted-by":"publisher","first-page":"6955","DOI":"10.1038\/ncomms7955","article-title":"Correction of human phospholamban R14del mutation associated with cardiomyopathy using targeted nucleases and combination therapy","volume":"6","author":"Karakikes","year":"2015","journal-title":"Nat Commun"},{"key":"B63","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1016\/j.jacc.2018.08.2181","article-title":"Dilated cardiomyopathy due to BLC2-associated athanogene 3 (BAG3) mutations","volume":"72","author":"Dom\u00ednguez","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.cjca.2019.05.031","article-title":"Sex differences in the long-term prognosis of dilated cardiomyopathy","volume":"36","author":"Cannat\u00e0","year":"2020","journal-title":"Can J Cardiol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1016\/j.jacc.2010.09.084","article-title":"SCN5A Mutations associate with arrhythmic dilated cardiomyopathy and commonly localize to the voltage-sensing mechanism","volume":"57","author":"McNair","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1093\/cvr\/cvw234","article-title":"Multilevel analyses of SCN5A mutations in arrhythmogenic right ventricular dysplasia\/cardiomyopathy suggest non-canonical mechanisms for disease pathogenesis","volume":"113","author":"te Riele","year":"2017","journal-title":"Cardiovasc Res"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1016\/j.jacc.2012.05.050","article-title":"R222q SCN5A mutation is associated with reversible ventricular ectopy and dilated cardiomyopathy","volume":"60","author":"Mann","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.jchf.2023.10.009","article-title":"Sex differences in the clinical presentation and natural history of dilated cardiomyopathy","volume":"12","author":"Owen","year":"2024","journal-title":"JACC Heart Failure"},{"key":"B69","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1093\/eurjhf\/hfs191","article-title":"Gender-specific differences in major cardiac events and mortality in lamin A\/C mutation carriers","volume":"15","author":"van Rijsingen","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"B70","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/nrcardio.2009.105","article-title":"Gender differences in the cardiovascular effect of sex hormones","volume":"6","author":"Vitale","year":"2009","journal-title":"Nat Rev Cardiol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1016\/j.jacc.2016.08.058","article-title":"Long-Term arrhythmic and nonarrhythmic outcomes of lamin A\/C mutation carriers","volume":"68","author":"Kumar","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"e005220","DOI":"10.1161\/CIRCHEARTFAILURE.118.005220","article-title":"Clinical phenotype and genotype associations with improvement in left ventricular function in dilated cardiomyopathy","volume":"11","author":"Verdonschot","year":"2018","journal-title":"Circulation Heart Failure"},{"key":"B73","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.cardfail.2018.03.004","article-title":"Genetic evaluation of cardiomyopathy-A heart failure society of America practice guideline","volume":"24","author":"Hershberger","year":"2018","journal-title":"J Card Fail"},{"key":"B74","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.ijcard.2020.09.036","article-title":"High prevalence of subtle systolic and diastolic dysfunction in genotype-positive phenotype-negative relatives of dilated cardiomyopathy patients","volume":"324","author":"Paldino","year":"2021","journal-title":"Int J Cardiol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.jacc.2021.11.045","article-title":"Echocardiographic deformation imaging for early detection of genetic cardiomyopathies","volume":"79","author":"Taha","year":"2022","journal-title":"JACC Review Topic of the Week. Journal of the American College of Cardiology"},{"key":"B76","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/s41569-020-00435-x","article-title":"Myocarditis and inflammatory cardiomyopathy: current evidence and future directions","volume":"18","author":"Tsch\u00f6pe","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1002\/ejhf.665","article-title":"Relevance of cardiac parvovirus B19 in myocarditis and dilated cardiomyopathy: review of the literature","volume":"18","author":"Verdonschot","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"B78","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/nrcardio.2015.108","article-title":"Viral myocarditis\u2013diagnosis, treatment options, and current controversies","volume":"12","author":"Pollack","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1161\/CIRCULATIONAHA.105.548156","article-title":"Viral persistence in the myocardium is associated with progressive cardiac dysfunction","volume":"112","author":"K\u00fchl","year":"2005","journal-title":"Circulation"},{"key":"B80","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1161\/CIRCHEARTFAILURE.110.958249","article-title":"Myocardial parvovirus B19 persistence: lack of association with clinicopathologic phenotype in adults with heart failure","volume":"4","author":"Stewart","year":"2011","journal-title":"Circulation Heart Failure"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1056\/NEJMc0911362","article-title":"Human parvovirus B19-associated myocarditis","volume":"362","author":"Bock","year":"2010","journal-title":"N Engl J Med"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1016\/0735-1097(90)92821-I","article-title":"Novel organ-specific circulating cardiac autoantibodies in dilated cardiomyopathy","volume":"15","author":"Caforio","year":"1990","journal-title":"J Am Coll Cardiol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1161\/01.RES.64.2.179","article-title":"Antibodies to the ADP\/ATP carrier, an autoantigen in myocarditis and dilated cardiomyopathy, penetrate into myocardial cells and disturb energy metabolism in vivo","volume":"64","author":"Schulze","year":"1989","journal-title":"Circ Res"},{"key":"B84","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.ahj.2008.02.015","article-title":"Potential role of antibodies against cardiac kv channel-interacting protein 2 in dilated cardiomyopathy","volume":"156","author":"Landsberger","year":"2008","journal-title":"Am Heart J"},{"key":"B85","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.ijcard.2014.10.165","article-title":"Passive transfer of affinity-purified anti-heart autoantibodies (AHA) from sera of patients with myocarditis induces experimental myocarditis in mice","volume":"179","author":"Caforio","year":"2015","journal-title":"Int J Cardiol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/S0735-1097(02)02075-2","article-title":"Autoantibodies produced against sarcolemmal na-K-ATPase: possible upstream targets of arrhythmias and sudden death in patients with dilated cardiomyopathy","volume":"40","author":"Baba","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1161\/CIRCRESAHA.111.243360","article-title":"Autoantibodies in heart failure and cardiac dysfunction","volume":"110","author":"Kaya","year":"2012","journal-title":"Circ Res"},{"key":"B88","doi-asserted-by":"publisher","first-page":"3630","DOI":"10.4049\/jimmunol.139.11.3630","article-title":"Cardiac myosin induces myocarditis in genetically predisposed mice","volume":"139","author":"Neu","year":"1987","journal-title":"J Immunol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1161\/CIRCULATIONAHA.106.641472","article-title":"Prospective familial assessment in dilated cardiomyopathy: cardiac autoantibodies predict disease development in asymptomatic relatives","volume":"115","author":"Caforio","year":"2007","journal-title":"Circulation"},{"key":"B90","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00246-014-1022-3","article-title":"Evaluation of the diagnostic work-up in children with myocarditis and idiopathic dilated cardiomyopathy","volume":"36","author":"den Boer","year":"2015","journal-title":"Pediatr Cardiol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1161\/CIRCULATIONAHA.121.058457","article-title":"Genetic architecture of acute myocarditis and the overlap with inherited cardiomyopathy","volume":"146","author":"Lota","year":"2022","journal-title":"Circulation"},{"key":"B92","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1161\/01.CIR.94.5.983","article-title":"Arrhythmogenic right ventricular cardiomyopathy. Dysplasia, dystrophy, or myocarditis?","volume":"94","author":"Basso","year":"1996","journal-title":"Circulation"},{"key":"B93","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.jacbts.2021.06.001","article-title":"Myopathic cardiac genotypes increase risk for myocarditis","volume":"6","author":"Kontorovich","year":"2021","journal-title":"JACC Basic to Translational Science"},{"key":"B94","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1002\/ejhf.1138","article-title":"The innate immune system in chronic cardiomyopathy: a European society of cardiology (ESC) scientific statement from the working group on myocardial function of the ESC","volume":"20","author":"Frantz","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"B95","doi-asserted-by":"publisher","first-page":"H573","DOI":"10.1152\/ajpheart.00425.2024","article-title":"Gene expression networks in endothelial cells from failing human hearts","volume":"327","author":"Wirth","year":"2024","journal-title":"American Journal of Physiology Heart and Circulatory Physiology"},{"key":"B96","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/s41577-018-0065-8","article-title":"Cardioimmunology: the immune system in cardiac homeostasis and disease","volume":"18","author":"Swirski","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.3390\/medicina59071246","article-title":"The molecular role of immune cells in dilated cardiomyopathy","volume":"59","author":"Wang","year":"2023","journal-title":"Medicina (Kaunas, Lithuania)"},{"key":"B98","doi-asserted-by":"publisher","first-page":"116159","DOI":"10.1016\/j.biopha.2024.116159","article-title":"Immune cells and related cytokines in dilated cardiomyopathy","volume":"171","author":"Zhang","year":"2024","journal-title":"Biomed Pharmacother"},{"key":"B99","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.yjmcc.2010.10.033","article-title":"Transforming growth factor (TGF)-\u03b2 signaling in cardiac remodeling","volume":"51","author":"Dobaczewski","year":"2011","journal-title":"J Mol Cell Cardiol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"e003870","DOI":"10.1161\/CIRCHEARTFAILURE.117.003870","article-title":"NOD2 (nucleotide-binding oligomerization domain 2) is a Major pathogenic mediator of coxsackievirus B3-induced myocarditis","volume":"10","author":"Tsch\u00f6pe","year":"2017","journal-title":"Circulation Heart Failure"},{"key":"B101","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.3390\/ijms25021082","article-title":"The role of pro-inflammatory cytokines in the pathogenesis of cardiovascular disease","volume":"25","author":"Zhang","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B102","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1172\/JCI30634","article-title":"IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system","volume":"117","author":"Sanada","year":"2007","journal-title":"J Clin Invest"},{"key":"B103","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1161\/01.CIR.0000047274.66749.FE","article-title":"Identification of serum soluble ST2 receptor as a novel heart failure biomarker","volume":"107","author":"Weinberg","year":"2003","journal-title":"Circulation"},{"key":"B104","doi-asserted-by":"publisher","first-page":"e005615","DOI":"10.1161\/CIRCIMAGING.116.005615","article-title":"Imaging to diagnose and manage patients in heart failure with reduced ejection fraction","volume":"10","author":"Nagueh","year":"2017","journal-title":"Circulation Cardiovascular Imaging"},{"key":"B105","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","article-title":"2023 ESC guidelines for the management of cardiomyopathies","volume":"44","author":"Arbelo","year":"2023","journal-title":"Eur Heart J"},{"key":"B106","doi-asserted-by":"publisher","first-page":"e007405","DOI":"10.1161\/CIRCHEARTFAILURE.120.007405","article-title":"Management of acute myocarditis and chronic inflammatory cardiomyopathy: an expert consensus document","volume":"13","author":"Ammirati","year":"2020","journal-title":"Circulation Heart Failure"},{"key":"B107","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1002\/ejhf.2190","article-title":"Heart failure association of the ESC, heart failure society of America and Japanese heart failure society position statement on endomyocardial biopsy","volume":"23","author":"Seferovi\u0107","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"B108","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/jcdd9010024","article-title":"Endomyocardial biopsy in pediatric myocarditis and dilated cardiomyopathy: a tool in search for a role","volume":"9","author":"Pilati","year":"2022","journal-title":"J Cardiovasc Dev Dis"},{"key":"B109","doi-asserted-by":"publisher","first-page":"103755","DOI":"10.1016\/j.autrev.2025.103755","article-title":"Frequency of autoantibodies and their associated clinical characteristics and outcomes in patients with dilated cardiomyopathy: a systematic review and meta-analysis","volume":"24","author":"Zhang","year":"2025","journal-title":"Autoimmun Rev"},{"key":"B110","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1093\/eurheartj\/ehp249","article-title":"Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study","volume":"30","author":"Frustaci","year":"2009","journal-title":"Eur Heart J"},{"key":"B111","doi-asserted-by":"publisher","first-page":"342","DOI":"10.3389\/fped.2019.00342","article-title":"Corticosteroids and intravenous immunoglobulin in pediatric myocarditis: a meta-analysis","volume":"7","author":"Li","year":"2019","journal-title":"Front Pediatr"},{"key":"B112","doi-asserted-by":"publisher","first-page":"430","DOI":"10.3389\/fped.2019.00430","article-title":"Immunosuppressive treatment for myocarditis in the pediatric population: a meta-analysis","volume":"7","author":"He","year":"2019","journal-title":"Front Pediatr"},{"key":"B113","doi-asserted-by":"publisher","first-page":"3463","DOI":"10.1093\/eurheartj\/ehac348","article-title":"Immunosuppressive therapy in virus-negative inflammatory cardiomyopathy: 20-year follow-up of the TIMIC trial","volume":"43","author":"Chimenti","year":"2022","journal-title":"Eur Heart J"},{"key":"B114","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1016\/j.amjcard.2013.01.287","article-title":"Effects of interleukin-1 blockade with anakinra on adverse cardiac remodeling and heart failure after acute myocardial infarction [from the Virginia commonwealth university-anakinra remodeling trial (2) (VCU-ART2) pilot study]","volume":"111","author":"Abbate","year":"2013","journal-title":"Am J Cardiol"},{"key":"B115","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1016\/j.jacc.2021.02.049","article-title":"Randomized trial of interleukin-6 receptor inhibition in patients with acute ST-segment elevation myocardial infarction","volume":"77","author":"Broch","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"B116","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1152\/physrev.00015.2009","article-title":"Myocardial fatty acid metabolism in health and disease","volume":"90","author":"Lopaschuk","year":"2010","journal-title":"Physiol Rev"},{"key":"B117","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nrcardio.2016.203","article-title":"Expert consensus document: mitochondrial function as a therapeutic target in heart failure","volume":"14","author":"Brown","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"B118","doi-asserted-by":"publisher","first-page":"100644","DOI":"10.1016\/j.ahjo.2025.100644","article-title":"Cardiomyopathy in valosin-containing protein multisystem proteinopathy: evaluation, diagnosis, and management","volume":"60","author":"Chan","year":"2025","journal-title":"American Heart Journal Plus"},{"key":"B119","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1093\/eurheartj\/ehx808","article-title":"Titin cardiomyopathy leads to altered mitochondrial energetics, increased fibrosis and long-term life-threatening arrhythmias","volume":"39","author":"Verdonschot","year":"2018","journal-title":"Eur Heart J"},{"key":"B120","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1016\/j.jacc.2023.08.014","article-title":"International consensus on differential diagnosis and management of patients with danon disease: jACC state-of-the-art review","volume":"82","author":"Hong","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"B121","doi-asserted-by":"publisher","first-page":"756593","DOI":"10.3389\/fped.2021.756593","article-title":"Review of insulin resistance in dilated cardiomyopathy and implications for the pediatric patient short title: insulin resistance DCM and pediatrics","volume":"9","author":"Mak","year":"2021","journal-title":"Front Pediatr"},{"key":"B122","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1161\/CIRCRESAHA.121.318241","article-title":"Cardiac energy metabolism in heart failure","volume":"128","author":"Lopaschuk","year":"2021","journal-title":"Circ Res"},{"key":"B123","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1161\/CIRCULATIONAHA.115.017545","article-title":"Evidence for intramyocardial disruption of lipid metabolism and increased myocardial ketone utilization in advanced human heart failure","volume":"133","author":"Bedi","year":"2016","journal-title":"Circulation"},{"key":"B124","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1016\/j.jacc.2020.12.065","article-title":"Therapeutic potential of ketone bodies for patients with cardiovascular disease: jACC state-of-the-art review","volume":"77","author":"Yurista","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"B125","first-page":"SR35","article-title":"Myocardial redox stress and remodeling in metabolic syndrome, type 2 diabetes mellitus, and congestive heart failure","volume":"9","author":"Hayden","year":"2003","journal-title":"Med Sci Monit"},{"key":"B126","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1007\/s00246-022-02983-0","article-title":"Early clinical experience with dapagliflozin in children with heart failure","volume":"44","author":"Newland","year":"2023","journal-title":"Pediatr Cardiol"},{"key":"B127","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"Cardiovascular and renal outcomes with empagliflozin in heart failure","volume":"383","author":"Packer","year":"2020","journal-title":"N Engl J Med"},{"key":"B128","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1007\/s00246-025-04025-x","article-title":"Use of SGLT2 inhibitors in pediatric heart failure: a multi-center study","volume":"47","author":"Butts","year":"2025","journal-title":"Pediatr Cardiol"},{"key":"B129","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jchf.2018.07.015","article-title":"Iron deficiency in heart failure: an overview","volume":"7","author":"Haehling","year":"2019","journal-title":"JACC Heart Failure"},{"key":"B130","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","article-title":"Ferric carboxymaltose in patients with heart failure and iron deficiency","volume":"361","author":"Anker","year":"2009","journal-title":"N Engl J Med"},{"key":"B131","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1016\/j.amjcard.2017.08.023","article-title":"Iron laboratory studies in pediatric patients with heart failure from dilated cardiomyopathy","volume":"120","author":"Higgins","year":"2017","journal-title":"Am J Cardiol"},{"key":"B132","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.healun.2023.11.014","article-title":"Iron deficiency and anemia in pediatric dilated cardiomyopathy are associated with clinical, biochemical, and hematological markers of severe disease and adverse outcomes","volume":"43","author":"Luxford","year":"2024","journal-title":"J Heart Lung Transplant"},{"key":"B133","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1016\/S0140-6736(22)02083-9","article-title":"Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial","volume":"400","author":"Kalra","year":"2022","journal-title":"Lancet (London, England)"},{"key":"B134","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1016\/S0140-6736(20)32339-4","article-title":"Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial","volume":"396","author":"Ponikowski","year":"2020","journal-title":"Lancet (London, England)"},{"key":"B135","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1002\/ejhf.2810","article-title":"Intravenous iron in patients with heart failure and iron deficiency: an updated meta-analysis","volume":"25","author":"Graham","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"B136","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1017\/S1047951121004066","article-title":"Poor efficacy of oral iron replacement therapy in pediatric patients with heart failure","volume":"32","author":"Puri","year":"2022","journal-title":"Cardiol Young"},{"key":"B137","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/j.jacc.2019.12.059","article-title":"Diuretic therapy for patients with heart failure: jACC state-of-the-art review","volume":"75","author":"Felker","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"B138","doi-asserted-by":"publisher","first-page":"2836","DOI":"10.1016\/j.jacc.2020.04.021","article-title":"Abnormalities of potassium in heart failure: jACC state-of-the-art review","volume":"75","author":"Ferreira","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"B139","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1056\/NEJMoa2509542","article-title":"Increasing the potassium level in patients at high risk for ventricular arrhythmias","volume":"393","author":"J\u00f8ns","year":"2025","journal-title":"N Engl J Med"},{"key":"B140","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1253\/circrep.CR-25-0175","article-title":"Safety and efficacy of intravenous magnesium for torsade de pointes\u2014a scoping review","volume":"7","author":"Sangawa","year":"2025","journal-title":"Circulation Reports"},{"key":"B141","doi-asserted-by":"publisher","first-page":"924","DOI":"10.3350\/cmh.2023.0090","article-title":"Evidence-based hyponatremia management in liver disease","volume":"29","author":"Ryu","year":"2023","journal-title":"Clin Mol Hepatol"},{"key":"B142","doi-asserted-by":"publisher","first-page":"341","DOI":"10.3390\/antiox9040341","article-title":"Coenzyme Q10: clinical applications in cardiovascular diseases","volume":"9","author":"Martelli","year":"2020","journal-title":"Antioxidants (Basel, Switzerland)"},{"key":"B143","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s12325-011-0091-4","article-title":"Creatine phosphate: pharmacological and clinical perspectives","volume":"29","author":"Strumia","year":"2012","journal-title":"Adv Ther"},{"key":"B144","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1016\/S0196-0644(86)80946-5","article-title":"Hemodynamics and metabolic effects of fructose 1\u20136 diphosphate in ischemia and shock\u2013experimental and clinical observations","volume":"15","author":"Markov","year":"1986","journal-title":"Ann Emerg Med"},{"key":"B145","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N Engl J Med"},{"key":"B146","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.jacbts.2020.02.004","article-title":"Mechanisms of cardiovascular benefits of sodium glucose co-transporter 2 (SGLT2) inhibitors: a state-of-the-art review","volume":"5","author":"Lopaschuk","year":"2020","journal-title":"JACC Basic to Translational Science"},{"key":"B147","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1016\/j.jacc.2012.05.054","article-title":"Left ventricular midwall fibrosis as a predictor of mortality and morbidity after cardiac resynchronization therapy in patients with nonischemic cardiomyopathy","volume":"60","author":"Leyva","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"B148","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/ejhf.1103","article-title":"Evolving concepts in dilated cardiomyopathy","volume":"20","author":"Merlo","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"B149","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1016\/j.amjcard.2013.07.007","article-title":"Clinical implications of serial serum N-terminal prohormone brain natriuretic peptide levels in the prediction of outcome in children with dilated cardiomyopathy","volume":"112","author":"Kim","year":"2013","journal-title":"Am J Cardiol"},{"key":"B150","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1002\/ejhf.3306","article-title":"A nationwide, population-based study on specialized care for acute heart failure throughout the COVID-19 pandemic","volume":"26","author":"Cannata","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"B151","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1161\/CIRCRESAHA.120.315855","article-title":"Gene therapy for the heart lessons learned and future perspectives","volume":"126","author":"Cannat\u00e0","year":"2020","journal-title":"Circ Res"},{"key":"B152","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jacbts.2021.07.012","article-title":"Translation of new and emerging therapies for genetic cardiomyopathies","volume":"7","author":"Helms","year":"2022","journal-title":"JACC Basic to Translational Science"},{"key":"B153","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1146\/annurev.genom.6.080604.162132","article-title":"The genetic basis for cardiac remodeling","volume":"6","author":"Ahmad","year":"2005","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"B154","doi-asserted-by":"publisher","first-page":"eade1633","DOI":"10.1126\/scitranslmed.ade1633","article-title":"Precise genomic editing of pathogenic mutations in RBM20 rescues dilated cardiomyopathy","volume":"14","author":"Nishiyama","year":"2022","journal-title":"Sci Transl Med"},{"key":"B155","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41591-022-02190-7","article-title":"Efficient in vivo genome editing prevents hypertrophic cardiomyopathy in mice","volume":"29","author":"Reichart","year":"2023","journal-title":"Nat Med"},{"key":"B156","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/s41591-022-02176-5","article-title":"Base editing correction of hypertrophic cardiomyopathy in human cardiomyocytes and humanized mice","volume":"29","author":"Chai","year":"2023","journal-title":"Nat Med"},{"key":"B157","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1161\/CIR.0000000000001151","article-title":"Treatment strategies for cardiomyopathy in children: a scientific statement from the American Heart Association","volume":"148","author":"Bogle","year":"2023","journal-title":"Circulation"},{"key":"B158","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1097\/TP.0000000000001672","article-title":"The utility of cardiopulmonary exercise testing for the prediction of outcomes in ambulatory children with dilated cardiomyopathy","volume":"101","author":"Chen","year":"2017","journal-title":"Transplantation"},{"key":"B159","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1177\/1474515119876148","article-title":"Emotional and behavioral problems in children with dilated cardiomyopathy","volume":"19","author":"van Der Mheen","year":"2020","journal-title":"Eur J Cardiovasc Nurs"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1888470\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T08:39:10Z","timestamp":1786091950000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1888470\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,7]]},"references-count":159,"alternative-id":["10.3389\/fcvm.2026.1888470"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1888470","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,7]]},"article-number":"1888470"}}